EN
HI
Alivus Life Sciences share price chart
Alivus Life Sciences Share Key Metrics
Volume
85268.00
Market Cap
16321.89 CR
LTQ@LTP
17@1329.80
ATP
1331.2
Var Margin
16.99 %
Circuit Range
1063.9-1595.7
Delivery %
35.9 %
Value
11.35 CR
ASM/GSM
No
Market Lot
1
Summary
ALIVUS stock price is ₹1329.8 as of 9 Aug, 2026. The stock intraday movement has stayed between ₹1315.50 and ₹1345.00, while Alivus Life Sciences share price 52 week high low is ₹819.00 & ₹1377.90.
In terms of trading activity, ALIVUS share price has recorded a volume of 85,268 shares. The Alivus Life Sciences has a market cap of ₹122739448. The stock’s Average Traded Price (ATP) stands at ₹1331.20, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 17 @ ₹1329.80.
The Alivus Life Sciences upper circuit limit is ₹1595.70 & The Alivus Life Sciences lower circuit limit is ₹1063.90, with a Value of ₹11.35 CR. The Delivery Percentage for the day is 35.9%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Alivus Life Sciences Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
64.26
Sector P/B
3.26
Sec. Div. Yield
0.52
Alivus Life Sciences Resistance and Support
Pivot 1338.57
Resistance
First Resistance
1364.54
Second Resistance
1403.87
Third Resistance
1429.84
Support
First Support
1299.24
Second Support
1273.27
Third Support
1233.94
Alivus Life Sciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 07 2026 | 1329.5 | 1329.8 | 0.35% | 1345 | 1315.5 |
| Thu Aug 06 2026 | 1329.9 | 1325.19 | -0.44% | 1377.9 | 1312.59 |
| Wed Aug 05 2026 | 1335 | 1331 | -0.36% | 1338.59 | 1304 |
Alivus Life Sciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-30 | Quarterly Results |
| 2026-05-14 | Audited Results & Final Dividend |
| 2026-01-22 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-15 | Audited Results & Final Dividend |
| 2025-01-23 | Quarterly Results |
| 2024-10-24 | Quarterly Results |
Alivus Life Sciences News
Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Alivus Life Sciences will host an in-person investor/analyst meet on August 12, 2026. The meeting at Emkay Confluence, Mumbai, will include both group and one-on-one sessions for investors and analysts.
Aug 07 2026 12:29:19
Alivus Life Sciences Ltd - 543322 - Intimation Of Record Date For Dividend
Alivus Life Sciences sets September 1, 2026, as Record Date for its final dividend of ₹5.00 per equity share for FY26. Payment for eligible shareholders will commence on or after September 11, 2026, subject to AGM approval.
Aug 06 2026 15:02:02
Read More
Alivus Life Sciences Management
| Name | Position |
|---|---|
| Rudalf Corriea | Company Secretary & Compliance Officer |
| Hiren K Patel | Chairman |
Alivus Life Sciences Similar Stocks
Jubilant Pharmova Ltd.
932.00
5.75 (0.62%)
Concord Biotech Ltd.
1365.00
-9.70 (0.71%)
Vijaya Diagnostic Centre Ltd.
1351.10
-18.70 (1.37%)
Shilpa Medicare Ltd.
759.75
20.95 (2.84%)
CORONA Remedies Ltd.
2058.80
13.30 (0.65%)
Park Medi World Ltd.
292.25
0.00 (0.00%)
Marksans Pharma Ltd.
273.85
4.95 (1.84%)
Viyash Scientific Ltd.
277.00
4.35 (1.60%)
Metropolis Healthcare Ltd.
563.20
-1.40 (0.25%)
Alivus Life Sciences FAQs
The Buying Price of Alivus Life Sciences share is 1329.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Alivus Life Sciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alivus Life Sciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Alivus Life Sciences shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Alivus Life Sciences shares is 0. Useful to assess the stock's value relative to its book value.
To assess Alivus Life Sciences’s valuation compare Sector P/E, P/B which are 64.26 & 3.26 with sector averages, along with growth rates and financial metrics.
The Market Cap of Alivus Life Sciences is 16321.89 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Alivus Life Sciences share price is 1377.90 & 819.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Alivus Life Sciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
